Hester Biosciences Ltd Share Price Today - Hester Biosciences Ltd Stock Price Live NSE/BSE

Hester Biosciences Ltd

NSE: HESTERBIO BSE: 524669

₹1395

(-1.96%)

Sat, 28 Mar 2026, 05:45 am

MTF 5xInvest in Hester Biosciences Ltd with 5x Leverage Buy with MTF

Market Cap11.85B

PE Ratio28.98

Dividend0.50

Health Technology

Pharmaceuticals: Major

24.5K

Hester Biosciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1122.01
Net Profit
28.83
P/B
3.39
Sector P/E
32.08
P/E
38.81
EV/EBITDA
18.42
Debt/Equity (Industry)
0.25
Interest Cover (Industry)
11.42
ROCE (Industry)
16.55
RONW (Industry)
14.50
ROE
9.51
ROCE
8.86
Debt/Equity
0.76
EPS (TTM)
48.13
Dividend Yield
0.53
Book Value
397.22
Interest Cover
4.12

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (4.4x coverage).
Hester Biosciences's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Hester Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Hester Biosciences is profitable, therefore cash runway is not a concern.

Cons

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Hester Biosciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
Hester Biosciences's level of debt (56.5%) compared to net worth is high (greater than 40%).
High level of physical assets or inventory.
Rajiv's remuneration is higher than average for companies of similar size in India.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	53.73	53.73	53.73	53.73	53.73
FII	0.51	0.53	0.04	0.87	0.59
DII	0.01	0.00	0.02	0.02	0.02
Public	45.75	45.74	46.20	45.38	45.65
Government	0	0	0	0	0

Technical Analysis

RSI

29.47

MACD

-45.73

50 DMA

1481.76

200 DMA

1719.27

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	1860.53	1708.23	1635.17	1555.93	1482.87	1403.63	1251.33
Fibonacci	1708.23	1650.05	1614.11	1555.93	1497.75	1461.81	1403.63
Camarilla	1603.98	1590.02	1576.06	1555.93	1548.14	1534.18	1520.22

Pivots Level: Classic

+304.60

1860.53

+152.30

1708.23

+79.23

1635.17

1555.93

Pivot Point

LTP: 1317.40

-73.07

1482.87

-152.30

1403.63

-304.60

1251.33

Moving Average

SMAEMA

Period

Value

10-EMA
1387.65
20-EMA
1426.90
30-EMA
1451.44
50-EMA
1485.71
100-EMA
1557.81
200-EMA
1665.95

Announcement Date	Purpose	Action	Ex Date
30 Jan 2026	board-meetings	Quarterly Results
11 Jul 2025	agm
06 Jul 2025	dividend	Final Dividend - Rs. - 7	06 Aug 2025
09 May 2025	dividend	₹7.00 Dividend /Share	06 Aug 2025
26 Jul 2024	agm
22 Jul 2024	dividend	Dividend - Rs 6 Per Share	22 Aug 2024
22 Jul 2024	agm	Annual General Meeting	23 Aug 2024
10 May 2024	dividend	₹6.00 Dividend /Share	23 Aug 2024
23 Aug 2023	agm
13 Aug 2023	dividend	Annual General Meeting/Dividend - Rs 8 Per Share	14 Sept 2023

Hester Biosciences Ltd

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Lupin Ltd

Sun Pharmaceutical Industries Ltd

Hester Biosciences Ltd About

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1987

Headquarters

CEO

Bhupendra V Gandhi

Employees

Contact

Website

http://www.hester.in

investor@hesterbiosciences.co.in

Phone

91-079-26445107

Location

1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006

Year	History
2013	Hester Biosciences received WHO GMP Certification. Hester launched Bivalent Marek's Disease Live Vaccine.
2014	Hester Biosciences board approved a scheme of amalgamation. The Company recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each for the financial year 2013-14.
2015	Hester Biosciences launched PPR vaccine and Goat Pox vaccine.
2020	Hester Nepal launched the thermo-tolerant PPR Vaccine.
2021	Hester to produce and commercialize Classical Swine Fever Vaccine and Sheep Pox Vaccine.

Client Name	Order Side	QTY	Avg Price	Date
HESTER COATINGS PRIVATE LIMITED	Sell	90000	732.1	22 Mar 2017
RAJIV DINESH GANDHI	Buy	90000	732.1	22 Mar 2017
K PAL JOY	Sell	47800	276	21 Aug 2014
SHIRIN DHUNJISHAW GHANDHI	Sell	60000	171.8	01 Jul 2014
PIYUSH BATUKBHAI DAVE	Buy	50000	110.23	24 Jun 2013
PIYUSH BATUKBHAI DAVE	Sell	50000	110.67	24 Jun 2013
JASHWANT JAGMOHAN SHAH	Sell	28505	126	22 Aug 2012
VIRAJBEN SIDDHARTHBHAI PATEL	Buy	28505	126	22 Aug 2012
N K PROTEINS LTD	Buy	35000	125.15	21 May 2012
VIMAL RAMNIKLAL AMBANI	Sell	35000	125.15	21 May 2012

Hester Biosciences Ltd News

Hester Biosciences Credit Ratings Downgraded by CARE

CARE Ratings downgrades Hester Biosciences' credit ratings across all facilities from BBB+ to BBB for long-term and A2 to A3+ for short-term facilities, citing financial performance concerns.

20 Mar 2026

companies

Hester Biosciences Divests 43.81% Stake in TLPL

Hester Biosciences agrees to sell its 43.81% stake in Texas Lifesciences Private Limited for Rs 92 million, ending subsidiary status post-transaction completion.

11 Mar 2026

co actions results

Hester Biosciences Re-appoints CEO via Postal Ballot

Hester Biosciences shareholders approve re-appointment of Rajiv Gandhi as CEO & Managing Director for 3 years through postal ballot with 99.54% votes in favor.

10 Mar 2026

stocks

Hester Biosciences Q3 FY26 Earnings Call Recording

Hester Biosciences makes Q3 FY26 earnings conference call audio recording available on company website following teleconference held on 30 January 2026.

30 Jan 2026

co actions results

Hester Biosciences Q3FY26 Results Call on Jan 30

Hester Biosciences Limited has scheduled an earnings conference call on January 30, 2026, at 2:00 PM IST to discuss Q3FY26 and nine-month financial results with senior management.

23 Jan 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800